Neuroscience company Neumora Therapeutics (NMRA) announced today that its experimental treatment for depression, Navacaprant, ...

Shares of the biotech Neumora Therapeutics began the first trading day of 2025 with a loss of more than 80% after the company ...

Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours ...

Duloxetine is an antidepressant, with a specific batch having been recalled due to the presence of potentially cancer-causing impurities.

Jan 2 (Reuters) - Neumora Therapeutics' (NMRA.O), opens new tab shares tumbled more than 80% on Thursday after its experimental depression drug failed to reduce symptoms such as sadness and ...

In a highly anticipated readout for the kappa opioid receptor class in major depressive disorder, Neumora’s navacaprant ...

During pregnancy, a health care provider will generally need to manage two different clinical scenarios: 1) starting medications, either for a woman with new-onset depression or for a woman ...

these antidepressants exhibit anticholinergic effects, but there’s inconsistent scientific evidence that they increase the risk of dementia. “If you’re taking these medications,” Hasan ...

Many anxiety and antidepressant medications, such as paroxetine, escitalopram, and duloxetine, may cause weight gain. But weight gain isn’t guaranteed and shouldn’t stop you from seeking ...